HIGH-DOSE CYCLOPHOSPHAMIDE AND HIGH-DOSE VP-16-213 FOR RECURRENT OR REFRACTORY SMALL-CELL LUNG-CANCER - A PHASE-II STUDY

被引：8
|
作者：
POSTMUS, PE
MULDER, NH
DEVRIESHOSPERS, HG
MULDER, POM
MAAS, A
MEINESZ, AF
SLEIJFER, DT
DEVRIES, EGE
机构：
[1] STATE UNIV GRONINGEN HOSP,DEPT MED ONCOL,9713 EZ GRONINGEN,NETHERLANDS
[2] STATE UNIV GRONINGEN HOSP,DEPT INTENS CARE MED,9713 EZ GRONINGEN,NETHERLANDS
[3] STATE UNIV GRONINGEN,DEPT MED MICROBIOL,9113 EZ GRONINGEN,NETHERLANDS
[4] RED CROSS BLOODBANK GRONINGEN DRENTHE,9713 EZ GRONINGEN,NETHERLANDS
来源：
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1985年 / 21卷 / 12期
关键词：
D O I：
10.1016/0277-5379(85)90239-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1467 / 1470
页数：4
相关论文
共 50 条
  • [1] HIGH-DOSE VP-16-213 WITH VINCRISTINE AND ADRIAMYCIN IN THE TREATMENT OF SMALL-CELL LUNG-CANCER (SCLC)
    CALMAN, F
    BELLAMY, D
    FAREBROTHER, M
    TIMOTHY, A
    BATEMAN, N
    RUBENS, R
    COSTELLO, J
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1982, 63 : 46 - 46
  • [2] HIGH-DOSE VP-16-213 MONOTHERAPY FOR REFRACTORY GERMINAL MALIGNANCIES - A PHASE-II STUDY
    WOLFF, SN
    JOHNSON, DH
    HAINSWORTH, JD
    GRECO, FA
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (04) : 271 - 274
  • [3] PHASE-II STUDY OF ORAL VP-16-213 IN SMALL-CELL LUNG-CANCER
    MATSUI, Y
    OSHIMA, S
    KADO, M
    NAKAYAMA, M
    SHIMOKATA, K
    SAKAI, S
    ITO, F
    CHIKATA, E
    HARA, K
    KANDA, T
    SHIMA, K
    TAKENAKA, S
    HOKAMA, S
    GENGA, K
    CANCER, 1987, 60 (12) : 2882 - 2885
  • [4] BRAIN METASTASES OF LUNG-CANCER - EXCESSIVE TOXICITY OF HIGH-DOSE VP-16-213
    VIENS, P
    LAGRANGE, JL
    THYSS, A
    AYELA, P
    FRENAY, M
    SCHNEIDER, M
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (12): : 1905 - 1906
  • [5] HIGH-DOSE ETOPOSIDE (VP-16) IN SMALL-CELL LUNG-CANCER
    GRECO, FA
    JOHNSON, DH
    HANDE, KR
    PORTER, LL
    HAINSWORTH, JD
    WOLFF, SN
    SEMINARS IN ONCOLOGY, 1985, 12 (01) : 42 - 44
  • [6] PHASE-II STUDY OF HIGH-DOSE EPIRUBICIN IN UNTREATED PATIENTS WITH SMALL-CELL LUNG-CANCER
    MACCHIARINI, P
    DANESI, R
    MARIOTTI, R
    MARCHETTI, A
    FAZZI, P
    BEVILACQUA, G
    MARIANI, M
    GIUNTINI, C
    DELTACCA, M
    ANGELETTI, CA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (04): : 302 - 307
  • [7] PHASE-II STUDY OF HIGH-DOSE ACLARUBICIN IN PREVIOUSLY TREATED PATIENTS WITH SMALL-CELL LUNG-CANCER
    JENSEN, PB
    LARSEN, SK
    STILBO, I
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 (03) : 219 - 220
  • [8] HIGH-DOSE IFOSFAMIDE IN SMALL-CELL LUNG-CANCER
    WARENIUS, HM
    HURMAN, DC
    COTTIER, B
    BRITISH JOURNAL OF CANCER, 1986, 54 (01) : 216 - 216
  • [9] HIGH-DOSE CYTARABINE IN SMALL-CELL LUNG-CANCER
    OSBORNE, RJ
    CLARK, PI
    SLEVIN, ML
    WRIGLEY, PFM
    CANCER TREATMENT REPORTS, 1987, 71 (04): : 417 - 418
  • [10] PHASE-II STUDY OF HIGH-DOSE EPIRUBICIN IN NON-SMALL-CELL LUNG-CANCER
    WILS, J
    UTAMA, I
    SALA, L
    SMEETS, J
    RIVA, A
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (11-12) : 1140 - 1141
12345